Creditors of Virgin Australia Holdings Ltd voted in favor of selling the airline to US private equity group Bain Capital, says administrator Deloitte.
The deal with Bain would allow unsecured creditors to get back 9 to 13 percent of their investment and involves a financial commitment of A$3.5 billion.
According to Deloitte, Virgin shares should be transferred to Bain Capital by Oct. 31.
Virgin Australia has been under voluntary administration since April due to the $5 billion it owes creditors.
Bain Capital Managing Director Mike Murphy described the purchase approval by creditors as an "important milestone in the airline’s recovery."
Under Bain’s business plan, Virgin will a third of its workforce as it focuses on being a domestic and short-haul international operator competing against Qantas Airways Ltd.
Virgin Chief Executive Paul Scurrah said the airline would exit unprofitable routes and would likely cede some market share to Qantas.
Before the pandemic, Virgin had spent a decade transforming itself from a low-cost carrier to a full-service rival to Qantas competing for corporate travelers, but that came at the cost of years of losses.
With Virgin planning to market itself more as a value-for-money option, Scurrah expects budget airlines to be under more pressure with the lower cost competition they will provide.


Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans 



